The Risk of Metabolic Syndrome in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Observational studies suggest an association between the incidence of rheumatoid arthritis (RA) and the prevalence of metabolic syndrome (MetS). However, the relationship between RA and MetS is controversial and research in this area is currently lacking. OBJECTIVE: The aim of this study was to assess whether the prevalence of MetS was higher in a group of RA patients compared to subjects without RA. DESIGN: A PubMed database search was conducted during April 2013 to identify observational studies of RA and risk of MetS. Reference lists of retrieved articles were also reviewed. Two authors independently extracted information on the study design, the characteristics of the study participants, exposure and outcome assessments, and the method used to control for potential confounding factors. A random-effects model was used for the risk estimates. RESULTS: Our meta-analysis of four cross-sectional controlled studies plus eight case-control studies involving a total of 2283 cases and 4403 controls identified a significant association between RA and risk of MetS, with an overall OR of 1.24 (95% CI, 1.03-1.50). CONCLUSION: This meta-analysis provides further evidence supporting patients with RA have a higher prevalence of MetS than subjects without RA. In addition, the geographic region of the population and the criteria used for MetS diagnosis could influence the association. However, these observations would need to be evaluated using prospective, randomized studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“patients with autoimmune diseases such as rheumatoid arthritis that are characterized by systemic inflammation have insulin resistance, dyslipidemia and hypertension, and that they have higher rates of metabolic syndrome, type 2 diabetes and CVD”
From Chronic inflammation in the etiology of disease across the life span (2019) · cites this paper as [37]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“We also calculated the I2 statistic, a quantitative measure of inconsistency across studies [8].”
MethodBias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Results from the random-effects model, which considers both within- and between-study variation [9], were used to compute the summary risk estimate.”
MethodGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · cited 1×
“To date, six definitions for MetS have been established: the Joint Consensus 2009 of the International Diabetes Federation (IDF) Task Force, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society and International Association for the Study o…”
MethodGrundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Eckel, R. H., Grundy, S. M., & Zimmet, P. Z. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,550
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210 · cited 1×
“Besides the central role of lipid storage, it has a major endocrine function secreting several hormones [47].”
BackgroundNonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820 · cited 1×
“To date, six definitions for MetS have been established: the Joint Consensus 2009 of the International Diabetes Federation (IDF) Task Force, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society and International Association for the Study o…”
MethodFord, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,710 · cited 1×
“MetS is responsible for a three-fold increase in the risk of atherosclerotic cardiovascular diseases(CVDs( and also increases mortality from CVD, as well as all-causes, in the general population [3].”
BackgroundGrundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Cardiovascular death in rheumatoid arthritis: A population‐based study
Maradit‐Kremers, H., Nicola, P. J., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20878 · Cited by 934 · cited 1×
“MetS is also considered an inflammatory state [39].”
BackgroundAdjusting for publication bias in the presence of heterogeneity
Terrin, N., Schmid, C. H., Lau, J., & Olkin, I. (2003) · Statistics in Medicine · doi:10.1002/sim.1461 · Cited by 809 · cited 1×
“incorrectly inferred if studies are heterogeneous [12].”
THE EPIDEMIOLOGY OF RHEUMATOID ARTHRITIS
Gabriel, S. E. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70201-5 · Cited by 782
Systematic reviews of evaluations of prognostic variables
Altman, D. G. (2001) · BMJ · doi:10.1136/bmj.323.7306.224 · Cited by 756 · cited 1×
“Therefore, they are subject to bias [56].”
Meta-analysis of Observational Studies in Epidemiology
Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., Moher, D., Becker, B. J., Sipe, T. A., & Thacker, S. B. (2000) · Cited by 473
The Metabolic Syndrome: More Than the Sum of Its Parts?
Reilly, M. P., & Rader, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000088846.10655.e0 · Cited by 465
Romeo, G. R., Lee, J., & Shoelson, S. E. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241869 · Cited by 382 · cited 1×
“An increased accumulation of macrophages occurring in obese adipose tissue has emerged as a key process in metabolic inflammation [46].”
BackgroundWulan, S. N., Westerterp, K. R., & Plasqui, G. (2010) · Maturitas · doi:10.1016/j.maturitas.2009.12.012 · Cited by 352 · cited 1×
“There is evidence that under a given body mass index (BMI), body fat percentage is greater in Caucasians than Asians [49].”
BackgroundChung, C. P., Oeser, A., Solus, J. F., Avalos, I., Gebretsadik, T., Shintani, A., Raggi, P., Sokka, T., Pincus, T., & Stein, C. M. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.01.004 · Cited by 333
Role of insulin resistance in human disease
Reaven, G. M. (1997) · Nutrition · doi:10.1016/s0899-9007(96)00380-2 · Cited by 320
Mok, C. C., Ko, G. T. C., Ho, L. Y., Yu, K. L., Chan, P. T., & To, C. H. (2011) · Arthritis Care & Research · doi:10.1002/acr.20363 · Cited by 199
Gualillo, O., González-Juanatey, J. R., & Lago, F. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.09.005 · Cited by 193 · cited 1×
“Adipokines exert potent modulatory actions on target tissues and cells involved in rheumatic disease, including cartilage, synovium, bone, and various immune cells [48].”
BackgroundDessein, P. H., Stanwix, A. E., & Joffe, B. I. (2002) · Arthritis Research & Therapy · doi:10.1186/ar428 · Cited by 183
Karvounaris, S., Sidiropoulos, P., Papadakis, J., Spanakis, E., Bertsias, G., Kritikos, H., Ganotakis, E., & Boumpas, D. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.053488 · Cited by 182 · cited 10×
“It may result in a reduction in CVD-related mortality as well as improvements in lipid and glucose profiles, such as lower triglyceride (TG) levels, higher HDL-C levels and lower plasma glucose [16].”
BackgroundInfluentialPark, Y.-B., Choi, H. K., Kim, M.-Y., Lee, W.-K., Song, J., Kim, D.-K., & Lee, S.-K. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01186-5 · Cited by 176 · cited 1×
“Corticosteroids may improve insulin sensitivity in patients with RA [57], Other studies have shown that a high disease activity is correlated with adverse lipid profile [58,59] and insulin resistance [45].”
BackgroundInsulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis
Montagna, G. L., Cacciapuoti, F., Buono, R., Manzella, D., Mennillo, G. A., Arciello, A., Valentini, G., & Paolisso, G. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.031 · Cited by 141 · cited 1×
“It is directly correlated with levels of interleukin 6, tumor necrosis factorα (TNFa), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) or coronary calcification [42-45].”
BackgroundMetabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis.
Dessein, P. H., Tobias, M., & Veller, M. (2006) · PubMed · Cited by 135
Toms, T. E., Panoulas, V. F., John, H., Douglas, K., & Kitas, G. D. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2765 · Cited by 133
da Cunha, V., Brenol, C. V., Brenol, J. C. T., Fuchs, S., Arlindo, E. M., Melo, I., Machado, C., Chaves, H., & Xavier, R. M. (2012) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2011.626443 · Cited by 125
Choi, H. K., & Seeger, J. D. (2005) · PubMed · Cited by 122
Dessein, P. H., Joffe, B. I., Stanwix, A. E., Botha, A. S., & Moomal, Z. (2002) · PubMed · Cited by 96
Zonana-Nacach, A., Santana-Sahagún, E., Jiménez-Balderas, F. J., & Camargo‐Coronel, A. (2008) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31816b2faa · Cited by 95 · cited 1×
“group [5,14-20] and one study used a cohort study design [21].”
MethodChannual, J. C., Wu, J. J., & Dann, F. J. (2009) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.01217.x · Cited by 93
Crowson, C. S., Myasoedova, E., Davis, J. M., Matteson, E. L., Roger, V. L., Therneau, T. M., Fitz‐Gibbon, P. D., Rodeheffer, R. J., & Gabriel, S. E. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100346 · Cited by 84
Toms, T. E., Panoulas, V. F., Douglas, K., Griffiths, H. R., & Kitas, G. D. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2578 · Cited by 81
Meigs, J. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2761 · Cited by 71 · cited 1×
“Despite questions about the existence of MetS, it is undoubtedly paramount to identify the presence of its components and establish adequate management strategies so that diabetes- and CVD-associated morbidity and mortality can be reduced [37].”
BackgroundDao, H.-H., Do, Q.-T., & Sakamoto, J. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3203 · Cited by 68
Vitamin D, Metabolic Dyslipidemia, and Metabolic Syndrome in Rheumatoid Arthritis
Baker, J. F., Mehta, N. N., Baker, D. G., Toedter, G. P., Shults, J., Feldt, J. M. V., & Leonard, M. B. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.01.025 · Cited by 63 · cited 1×
“group [5,14-20] and one study used a cohort study design [21].”
MethodGonzález-Gay, M. Á., Vázquez-Rodríguez, T. R., García‐Unzueta, M. T., Berja, A., Miranda-Filloy, J. A., Matias, J. M. D., González‐Juanatey, C., & Llorca, J. (2010) · PubMed · Cited by 63
Ormseth, M. J., Lipson, A., Alexopoulos, N. A., Hartlage, G. R., Oeser, A. M., Bian, A., Gebretsadik, T. S., Shintani, A., Raggi, P., & Stein, C. M. (2013) · Arthritis Care & Research · doi:10.1002/acr.22027 · Cited by 57
Santos, M. J., Vinagre, F., Silva, J. J., Gil, V. M., & Fonseca, J. E. (2010) · PubMed · Cited by 55
Pamuk, Ö. N., Ünlü, E., & Çakir, N. (2006) · PubMed · Cited by 50
Svenson, K. L. G., Lundqvist, G., WIDE, L. E., & Hällgren, R. (1987) · Metabolism · doi:10.1016/0026-0495(87)90129-6 · Cited by 48 · cited 1×
“Corticosteroids may improve insulin sensitivity in patients with RA [57], Other studies have shown that a high disease activity is correlated with adverse lipid profile [58,59] and insulin resistance [45].”
BackgroundBeyond the joints: Neurological involvement in rheumatoid arthritis
Ramos-Remus, C., Duran-Barragán, S., & Castillo-Ortiz, J. D. (2011) · Clinical Rheumatology · doi:10.1007/s10067-011-1841-z · Cited by 45
Dessein, P. H., Norton, G. R., Woodiwiss, A. J., Joffe, B. I., & Solomon, A. (2007) · PubMed · Cited by 45
Sahebari, M., Goshayeshi, L., Mirfeizi, Z., Rezaieyazdi, Z., Hatef, M. R., Ghayour‐Mobarhan, M., Akhlaghi, S., Sahebkar, A., & Ferns, G. A. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.111 · Cited by 44
Raterman, H. G., van Eijk, I. C., Voskuyl, A. E., Peters, M. J. L., Dijkmans, B. A. C., van Halm, V. P., Şimşek, S., Lems, W. F., & Nurmohamed, M. T. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.100776 · Cited by 38 · cited 1×
“group [5,14-20] and one study used a cohort study design [21].”
MethodThe frequency of metabolic syndrome in women with rheumatoid arthritis and in controls
Karimi, M., Mazloomzadeh, S., Kafan, S., & Amirmoghaddami, H. (2011) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2011.01595.x · Cited by 34
Goshayeshi, L., Saber, H., Sahebari, M., Rezaieyazdi, Z., Rafatpanah, H., Esmaily, H., & Goshayeshi, L. (2012) · Clinical Rheumatology · doi:10.1007/s10067-012-1995-3 · Cited by 32 · cited 2×
“group [5,14-20] and one study used a cohort study design [21].”
BackgroundMethodFerraccioli, G., & Gremese, E. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13211 · Cited by 31 · cited 1×
“group [5,14-20] and one study used a cohort study design [21].”
MethodLee, S., Kim, J., Lee, S. H., Kim, K.-H., Kim, J.-H., Yi, J.-W., Jung, W.-J., Park, Y. E., Park, S.-H., Lee, J.-W., et al. (2013) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2013.28.2.206 · Cited by 27
Karakoç (2012) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1001w · Cited by 26
Glucocorticoids upregulate high-affinity, high-density lipoprotein binding sites in rat hepatocytes
Bocharov, A. V., Huang, W., Tg, V., Zaitseva, E. V., Frolova, E. G., Rampal, P., & Bertolotti, R. (1995) · Metabolism · doi:10.1016/0026-0495(95)90185-x · Cited by 16 · cited 1×
“Concurrently, endogenous glucocorticoid hormones regulate high density lipoprotein (HDL) concentration in plasma by increasing synthesis and secretion of HDL by the liver [60].”
BackgroundUse of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome
Raterman, H. G., Voskuyl, A. E., Dijkmans, B. A. C., & Nurmohamed, M. T. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2805 · Cited by 8
Colony variability under the spotlight in animal models of arthritis
Robinson, J. H. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2653 · Cited by 8
Modulating TLR responses in systemic sclerosis via heme oxygenase-1
van Bon, L., Scharstuhl, A., Pennings, B., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.129627k
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s · cited 1×
“To date, six definitions for MetS have been established: the Joint Consensus 2009 of the International Diabetes Federation (IDF) Task Force, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society and International Association for the Study o…”
MethodKomuro (2001) · doi:10.1002/1529-0131(200112)44:12
Research works printed but not linked: 2
- M Gonzalez-Gay, 2010, Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-α therapy, Clin Exp Rheumatol, 28, 56
- M Sahebari, 2011, Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis. The Scientific, World J, 11, 1195, 10.1100/tsw.2011.111 · DOI
Cited by
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Tournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2019) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.08.001 · Cited by 375
“Both proinflammatory cytokines (IL-6, TNFα) and glucocorticoids promote insulin resistance in RA (20).”
BackgroundAtherosclerosis in rheumatoid arthritis: is it all about inflammation?
Skeoch, S., & Bruce, I. N. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.40 · Cited by 281
Subclinical hypothyroidism and type 2 diabetes: A systematic review and meta-analysis
Han, C., He, X., Xia, X., Li, Y., Shi, X., Shan, Z., & Teng, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135233 · Cited by 258
“We computed prevalence according to measurements reported previously [22, 23].”
MethodSelf-citationRheumatoid arthritis and metabolic syndrome
Kerekes, G., Nurmohamed, M. T., González-Gay, M. A., Seres, I., Paragh, G., Kardos, Z., Baráth, Z., Tamási, L., Soltész, P., & Szekanecz, Z. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.121 · Cited by 215
Metadata
- Authors
- Zhang, J., Fu, L., Shi, J., Chen, X., Li, Y., Ma, B., & Zhang, Y.
- Affiliations
- First Hospital of China Medical University (CN)
- China Medical University (CN)
- Corresponding author
- Fu, Lingyu
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-25
- Volume
- 8
- Issue
- 10
- Pages
- e78151
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3808281
- OpenAlex
- W2003877413
- Cited by
- 81
- References
- 68
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 6 · 2017: 13 · 2016: 14 · 2015: 7 · 2014: 6
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (30800944, 30671796)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- rheumatoid arthritis, metabolic syndrome, prevalence, risk factors, regional variation, confounding
- MeSH terms
- Arthritis, Rheumatoid, Cross-Sectional Studies, Humans, Prevalence, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.